SIH Partners’s Bristol-Myers Squibb BMY Stock Holding History

SIH Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-57,172	Closed	-$2.58M	–	220
2025 Q3	$2.58M	Buy	+57,172	New	+$2.67M	0.07%	83
2025 Q2	–	Sell	-32,215	Closed	-$1.96M	–	189
2025 Q1	$1.96M	Buy	+32,215	New	+$1.88M	0.07%	91

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

SIH Partners's BMY Position: Q4 2025 in Review

SIH Partners sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 57,172 shares — an estimated $2.58M sold.

SIH Partners first reported a position in BMY in Q1 2025 and held it in 2 quarters. The position peaked at $2.58M in Q3 2025. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

SIH Partners reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
SIH Partners sold 57,172 Bristol-Myers Squibb shares in Q4 2025, an estimated $2.58M.
SIH Partners first reported a position in Bristol-Myers Squibb in Q1 2025 and held it in 2 quarters.
SIH Partners's Bristol-Myers Squibb position peaked at $2.58M in Q3 2025.
2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on SIH Partners's 13F filing for Q4 2025, filed 17 Feb 2026.